Epithelial-to-mesenchymal transition: possible role in meningiomas
- PMID: 22201922
- DOI: 10.2741/E427
Epithelial-to-mesenchymal transition: possible role in meningiomas
Abstract
Epithelial-to-mesenchimal transition (EMT) is a process involved in invasion and metastasis of tumors. The occurrence of EMT during tumor progression resembles the developmental scenario and sheds light on important mechanisms for the initial step of metastasis - invasion where noninvasive tumor cells acquire motility and ultimately disseminate to distant organs. The hallmark of EMT is the loss of expression of the cell-cell adhesion molecule E-cadherin. The numerous reports by many authors as well as our own results indicate that E-cadherin plays a role in CNS tumors - meningiomas. Our studies showed that 73 % of meningiomas had downregulation of E-cadherin. Moreover, loss of heterozygosity of E-cadherin was observed in 32 % of meningiomas. Bound to E-cadherin in adherens junctions is beta-catenin, whose translocation to the nucleus is yet another molecular event involved in EMT. In our study beta-catenin was progressively upregulated from meningothelial to atypical, while 60 % of anaplastic meningiomas showed upregulation and nuclear localization of the protein. The elucidation of molecular mechanisms that govern EMT will offer new approaches and targets to restrain metastasis.
Similar articles
-
Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas.J Neurol Sci. 2017 Sep 15;380:112-121. doi: 10.1016/j.jns.2017.07.009. Epub 2017 Jul 8. J Neurol Sci. 2017. PMID: 28870549
-
Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin.Clin Neuropathol. 2005 Jan-Feb;24(1):8-12. Clin Neuropathol. 2005. PMID: 15696778
-
Altered expression of beta-catenin/E-cadherin in meningiomas.Histopathology. 2006 Aug;49(2):178-87. doi: 10.1111/j.1365-2559.2006.02440.x. Histopathology. 2006. PMID: 16879395
-
Bilateral Meningioma: A Case Report and Review of the Literature.Int J Mol Sci. 2022 Jan 21;23(3):1187. doi: 10.3390/ijms23031187. Int J Mol Sci. 2022. PMID: 35163107 Free PMC article. Review.
-
Role of Epithelial-Mesenchymal Transition in Tumor Progression.Biochemistry (Mosc). 2018 Dec;83(12):1469-1476. doi: 10.1134/S0006297918120052. Biochemistry (Mosc). 2018. PMID: 30878022 Review.
Cited by
-
Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling.Cancers (Basel). 2016 Jul 15;8(7):67. doi: 10.3390/cancers8070067. Cancers (Basel). 2016. PMID: 27429002 Free PMC article. Review.
-
miR-214-3p inhibits epithelial-to-mesenchymal transition and metastasis of endometrial cancer cells by targeting TWIST1.Onco Targets Ther. 2019 Nov 18;12:9449-9458. doi: 10.2147/OTT.S181037. eCollection 2019. Onco Targets Ther. 2019. PMID: 31819476 Free PMC article.
-
Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer.Am J Cancer Res. 2019 Apr 1;9(4):800-815. eCollection 2019. Am J Cancer Res. 2019. PMID: 31106005 Free PMC article.
-
Brain metastases from lung cancer show increased expression of DVL1, DVL3 and beta-catenin and down-regulation of E-cadherin.Int J Mol Sci. 2014 Jun 13;15(6):10635-51. doi: 10.3390/ijms150610635. Int J Mol Sci. 2014. PMID: 24933634 Free PMC article.
-
MicroRNA-155-5p suppresses the migration and invasion of lung adenocarcinoma A549 cells by targeting Smad2.Oncol Lett. 2018 Aug;16(2):2444-2452. doi: 10.3892/ol.2018.8889. Epub 2018 Jun 4. Oncol Lett. 2018. PMID: 30013636 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources